← FDA Drug Approvals (Drugs@FDA)

OLMESARTAN MEDOXOMIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2024-10-31

Drug application

FDA Application #

ANDA205499

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLMESARTAN MEDOXOMIL

Generic name

OLMESARTAN MEDOXOMIL

Active ingredients

OLMESARTAN MEDOXOMIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD V

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2024-10-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown